A. Soleiman
Impact in
- Oncology top 5%
- Lymphatic System and Diseases
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
Papers in
-
- Osteoarthritis Treatment and Mechanisms 4
-
- Renal Diseases and Glomerulopathies 2
- Chronic Kidney Disease and Diabetes 1
- Co-authors
- Dontscho Kerjaschki (2 shared papers)Silvana Breiteneder-Geleff (2 shared papers)G Schäffner (1 shared paper)Paul Meraner (1 shared paper)Romana Kalt (1 shared paper)K. Matsui (1 shared paper)Ludwig Erlacher (5 shared papers)Klaus Bobacz (4 shared papers)
- Journals
- European Journal of Clinical Investigation (3 papers)Nephrology Dialysis Transplantation (3 papers)Clinical Nephrology (2 papers)Clinical & Experimental Immunology (1 paper)Osteoarthritis and Cartilage (1 paper)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
A. Soleiman
17 papers receiving 911 citations
Peers
Comparison fields: 5 of 73
- Oncology 401
- Nephrology 103
- Transplantation 27
- Rheumatology 119
- Surgery 228
Countries citing papers authored by A. Soleiman
This map shows the geographic impact of A. Soleiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Soleiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Soleiman more than expected).
Fields of papers citing papers by A. Soleiman
This network shows the impact of papers produced by A. Soleiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Soleiman. The network helps show where A. Soleiman may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Soleiman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. | 1997 | 422 |
| 2 | 2004 | 80 | |
| 3 | [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma]. | 1999 | 73 |
| 4 | 2003 | 71 | |
| 5 | 2002 | 60 | |
| 6 | 2009 | 54 | |
| 7 | 2003 | 43 | |
| 8 | 2009 | 24 | |
| 9 | 2011 | 23 | |
| 10 | 2007 | 17 | |
| 11 | 2012 | 16 | |
| 12 | 2006 | 11 | |
| 13 | 2008 | 9 | |
| 14 | 2004 | 8 | |
| 15 | 2001 | 7 | |
| 16 | 2007 | 4 | |
| 17 | 2003 | 1 | |
| 18 | 2024 | 0 |
About A. Soleiman
A. Soleiman is a scholar working on Rheumatology, Nephrology, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 18 papers that have together received 923 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (4 papers), Vasculitis and related conditions (2 papers), Renal Diseases and Glomerulopathies (2 papers), Adolescent and Pediatric Healthcare (1 paper), Tuberculosis Research and Epidemiology (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Mycobacterium research and diagnosis (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Oncology (401 citations), Nephrology (103 citations), Transplantation (27 citations), Rheumatology (119 citations) and Surgery (228 citations). A. Soleiman has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Dontscho Kerjaschki, Silvana Breiteneder-Geleff, G Schäffner, Paul Meraner, Romana Kalt, K. Matsui, Ludwig Erlacher, Klaus Bobacz, W. Graninger and Reinhard Gruber. Their work appears in journals such as European Journal of Clinical Investigation, Nephrology Dialysis Transplantation, Clinical Nephrology, Clinical & Experimental Immunology and Osteoarthritis and Cartilage.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.